US Stock MarketDetailed Quotes
NVO Novo-Nordisk A/S
- 85.000
- -18.440-17.83%
Close Dec 20 16:00 ET
- 86.090
- +1.090+1.28%
Post 20:01 ET
378.77BMarket Cap28.86P/E (TTM)
86.530High81.500Low53.76MVolume82.720Open103.440Pre Close4.50BTurnover1.69%Turnover Ratio32.87P/E (Static)4.46BShares147.59352wk High22.62P/B271.14BFloat Cap81.50052wk Low1.48Dividend TTM3.19BShs Float147.593Historical High1.74%Div YieldTTM4.86%Amplitude-3.073Historical Low83.709Avg Price1Lot Size
Heat List
US
Overall
Symbol
Price
% Chg
No Data
Novo-Nordisk A/S Stock Forum
no idea whats up w/ nvo for entry but nvox is a new leaveraged ticker. it just started recently so hadn't had a chance to go up yet before tanking. this is the complete history of ticker.
$Defiance Daily Target 2X Long NVO ETF (NVOX.US)$
I made a difficult but crucial decision on Friday to sell off losing positions at pre-market which were moving downtrend so badly like $Novo-Nordisk A/S (NVO.US)$ , $D.R. Horton (DHI.US)$ , $Huntington Ingalls Industries (HII.US)$ , $MarketAxess (MKTX.US)$ . Especially obesity drug giant NVO which collapsed 25% at pre-market after disappointing trial results o...
loading...
I’d like to think that it was the result of some 9-dimensional formula with repeatable outputs…but in actuality, it was just financial Ultra Instinct (with even less consistency and internal logic than Goku’s powers)…
I got out of Novo for reasons ...
At the closing bell 4 pm ET, the S&P 500 climbed 1.28%, the Dow Jones Industrial Average climbed 1.52%, and the Nasdaq Composite Index climbed 1.21%.
MACRO
In macro, Personal Consumption Expenditure numbers came in lower than expected, 2.4% vs 2.5%, but trending higher...
$Novo-Nordisk A/S (NVO.US)$ Shares dropped 20% after a trial of the CagriSema obesity drug, which showed that patients lost 22.7% o...
Pick 2: $ASML Holding (ASML.US)$
Pick 3: $Nike (NKE.US)$
Pick 4: $Adobe (ADBE.US)$
Pick 5: $PepsiCo (PEP.US)$
No comment yet